Rafat Ansari

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Medicine, Oncology, Pharmacology +14

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Nasser H. Hanna, Paul A. Bunn, Corey J. Langer et al. · Journal of Clinical Oncology · 2006 · 678 citations · Full text

Medicine, Oncology, Pharmacology +10

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 496 citations

Medicine, Oncology, Radiation Oncology +15

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

Roy S. Herbst, Rafat Ansari, F. Bustin et al. · The Lancet · 2011 · 393 citations · Full text

Medicine, Oncology, Pharmacology +9

Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401

Arti Hurria, Constance Cirrincione, Hyman B. Muss et al. · Journal of Clinical Oncology · 2011 · 347 citations · Full text

Medicine, Geriatric Medicine, Oncology +15